NEXM, MIPI, NURO - Late Morning Pharmaceutical Gainers - source PicksThatMove.com

June 15, 2010 - PRLog -- Calgary, Alberta –PicksThatMove is pleased to bring investors special situation stocks which have a high potential for price appreciation.  These companies have interesting business models and they have to execute on the business development level to bring value to shareholders.  Some of our past picks had soared over 200%.  To view some of our profiled stocks, please visit our website at www.picksthatmove.com


Nexmed Inc , is a pharmaceutical and medical technology company with a focus on developing and commercializing therapeutic products based on its proprietary NexACT(r) drug delivery technology. The stock has been trading at a tight range between $0.31 and $0.35 this morning and is now currently sitting at $0.32 for a 12% increase.  

Molecular Insight Pharmaceuticals Inc , is a biopharmaceutical company focused on the research, development and commericalization of innovative molecular imaging.  They also focus on radiotherapeutics designed to improve patient diagnosis, treatment and management.  MIPÏ has seen a huge increase this late morning as they improved to $2.25 from $1.30 for a (+0.94, 71.8%) gain.

NeuroMetrix Inc , is currently trading at $1.30 after it opened this morning at $1.21 for a 12% increase. NURO is a science-based health care company that transforms patient care through neurotechnology. They also provide innovative products for preservation and restoration of nerve and spinal cord function.

About PicksThatMove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned here in and may profit in the event those shares rise in value.  Please follow us on Twitter and Facebook for further investment updates.  We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.